Benefits of Ablatherm HIFU

What are the Benefits of Ablatherm® HIFU?

HIFU is a non invasive treatment for localized prostate cancer.  Rather than using surgery or radiation, this treatment uses High Intensity Focused Ultrasound energy (sound waves) to destroy targeted areas of the prostate.   HIFU is one of the latest, state-of-the-art technologies using heat to destroy prostate tissue with pinpoint accuracy, leading to fewer side effects and a quicker recovery time.  As the procedure is non-invasive, the HIFU patient can usually return to normal activity after only a few days.

 

Maple Leaf HIFU treats hundreds of patients from around the world every year. We offer the only Ablatherm HIFU device in North America in our world class Toronto facility, in association with the U.S. Cleveland Clinic. Our physicians are top urologists trained in HIFU procedures. Call us today for more information on this effective prostate cancer treatment alternative.

The treatment of localized prostate cancer with High Intensity Focused Ultrasound (HIFU) has many benefits and advantages:

  • Destruction of the prostate tissue with no incident of injury to the rectum since parameters were updated in 2002.
  • Patient does not undergo any radiation exposure.
  • No hospital stay is required.
  • Treatment is performed under spinal anesthesia with IV Sedation.
  • Treatment can be repeated if necessary.
  • Other therapeutic alternatives can be considered in case of incomplete results.
  • Ablatherm® HIFU can be used for the treatment of local recurrences (i.e. after external beam radiotherapy)
  • There is no burning sensation as associated with radiotherapy.
  • Ablatherm® HIFU may be suitable for men who have a return of the prostate cancer following radiotherapy or cryotherapy.


Clinical Results

Many clinical studies show the effectiveness of HIFU treatments compared to traditional therapies.

An independent European study of 402 patients with localized prostate cancer that were treated with Ablatherm® HIFU, resulted in  87.2% of patients having no cancer found in their biopsies and normal PSA levels in 81.4% of treated patients. 

Another study showed that 86% of HIFU treated patients had no cancer found in their biopsy tests 9 years after treatment. 

View the 2012 published data from the largest North American clinical study on HIFU for prostate cancer .

finance hifu treatment